DXCM 80.04 (+5.57%)
US2521311074Medical Diagnostics & ResearchDiagnostics & Research

DexCom (DXCM) Competitor Comparison

We are evaluating the key criteria listed to compare DexCom (DXCM) against its competitors in the Diagnostics & Research industry.

Performance 10 years - DXCM ranking 6 / 58

These are the competitors of DexCom in the industry Diagnostics & Research ranked by performance 10 years
1. Heska HSKA
1.65K
2. Lantheus Holdings LNTH
1.36K
3. Medpace Holdings MEDP
1.1K
4. Natera NTRA
799.33
5. RadNet RDNT
752.29
6. DexCom DXCM
464.06
7. IDEXX Laboratories IDXX
457.52
8. Mettler-Toledo MTD
308.46
9. Thermo Fisher Scientific TMO
307.38
10. NeoGenomics NEO
293.53
11. Danaher DHR
292.02
12. Icon ICLR
291.82
13. Twist Bioscience TWST
268.77
14. PerkinElmer PKI
247.07
15. IQVIA Holdings IQV
227.26
16. Agilent Technologies A
225.06
17. Waters WAT
219.72
18. Charles River Laboratories CRL
190.9
19. CareDx CDNA
160.39
20. Laboratory Corp of America Holdings LH
151.52
21. Quest Diagnostics DGX
130.16
22. Exact Sciences EXAS
116
23. Syneos Health SYNH
113.83
24. Fulgent Genetics FLGT
99.13
25. Qiagen QGEN
81.4
26. Inotiv NOTV
78.17
27. Meridian Bioscience VIVO
60.69
28. National Research NRC
23.17
29. Guardant Health GH
14.13
30. Ortho Clinical Diagnostics Holdings OCDX
13.74
31. Anixa Biosciences ANIX
-10.33
32. Illumina ILMN
-26.39
33. Olink Holding OLK
-26.82
34. Bioventus BVS
-29.34
35. Neogen NEOG
-33.41
36. Sera Prognostics SERA
-41.51
37. Sotera Health SHC
-50.96
38. Myriad Genetics MYGN
-63.17
39. Global Cord Blood CO
-66.57
40. Exagen XGN
-69.35
41. Pacific Biosciences of California PACB
-73.63
42. MaxCyte MXCT
-75.04
43. DarioHealth DRIO
-75.47
44. Personalis PSNL
-75.64
45. Enzo Biochem ENZ
-77.8
46. MDxHealth MDXH
-81.4
47. Co-Diagnostics CODX
-83.5
48. Psychemedics PMD
-86.94
49. bioAffinity Technologies BIAF
-88.45
50. Biodesix BDSX
-88.45
51. SeqLL SQL
-95.22
52. Prenetics Global PRE
-95.29
53. Neuronetics STIM
-97
54. Aspira Womens Health AWH
-97.44
55. Interpace Biosciences IDXG
-98.24
56. Trinity Biotech TRIB
-98.9
57. Organovo Holdings ONVO
-99.26
58. Precipio PRPO
-99.8

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.